(PRBuzz.com) November 16, 2012 -- NDEI.org Interactive Case Study Explores ADA/EASD Recommendations for Individualized Treatment in Type 2 Diabetes
The on-demand case study reinforces a patient-centered approach to managing hyperglycemia in type 2 diabetes recommended in a new position statement released by the American Diabetes Association (ADA)/European Association for the Study of Diabetes (EASD). Noted diabetes expert Silvio E. Inzucchi, MD, provides clinical perspectives on appropriate treatment and management throughout the case.
"The new ADA/EASD position statement provides a sensible approach for therapy selection," said Dr Inzucchi, a professor of medicine (endocrinology), Clinical Director of the Section of Endocrinology, and Director of the Yale Diabetes Center at Yale University School of Medicine in New Haven, Connecticut. "Therapeutic choices must be carefully considered by the clinician, in conjunction with the patient."
The case study chronicles a 58-year-old male with uncontrolled type 2 diabetes and a history of cardiovascular disease, and ushers the learner through appropriate assessment of glycemic control, treatment options for glucose lowering, and implementation of the concepts discussed in the ADA/EASD position statement into clinical practice. Nearly 26 million US adults aged 20 years or older have diabetes, with type 2 diabetes accounting for about 95% of all cases. Appropriate management of hyperglycemia, or high blood sugar--the hallmark of diabetes--is complex, with an extensive array of treatment options available, causing confusion among physicians regarding optimal strategies for patients. The ADA/EASD joint statement provides general recommendations for therapy choices to address hyperglycemia.
Dr Inzucchi is lead author on the ADA/EASD position statement and an esteemed member of the NDEI Education Council. NDEI is a multi-component educational initiative addressing issues spanning the diabetes continuum, from epidemiology and pathophysiology of the disease and its associated complications and comorbidities, to the therapeutic options for prevention and treatment. Launched in 1996, NDEI is sponsored by KnowledgePoint360. Robust offerings on NDEI.org include a slide library featuring nearly 1,000 downloadable slides on topics exploring the spectrum of diabetes and associated conditions; on-demand programs, including webcasts, newsletters, and case studies; and patient education tools and resources. Membership is free and unlocks premium content offerings and educational opportunities. For more information, visit www.NDEI.org.
KnowledgePoint360 provides a broad range of healthcare information, communications, and advisory services from offices in the U.S., the U.K., and Germany, including digital solutions, training, benchmark-based advisory services, medical education, publication support, live educational meetings ranging from international congresses to dinner meetings, scientific content development, exhibit design, workflow and compliance solutions to support speaker programs, and strategic consulting.
Vice President/Independent Educational Initiatives
KnowledgePoint360 businesses include ACUMED, BlueMomentum, CircleScience, Clinical Bridges, CodonMedical, eMedFusion, FireKite, Gardiner-Caldwell Communications, GeoMed, InterPhase, Medex-Media, Physicians World, Physicians World Europe, Physicians World Speakers Bureau, Scientific Connexions, StemScientific, and TGaS Advisors. Headquarters are in Lyndhurst, N.J., with additional offices in Macclesfield, Tytherington, Maidenhead, and London, U.K.; Newtown and East Norriton, Pa., New York, Chicago, and San Bruno, Calif.; and Mannheim, Germany. For more information, visit www.knowledgepoint360.com.